From: Boolean network-based model of the Bcl-2 family mediated MOMP regulation
Bcl-2 | Full name of the protein | Binds to and inhibits | Ref. |
---|---|---|---|
protein | Â | Â | Â |
Antiapoptotic | Â | Â | Â |
Members: | Â | Â | Â |
Mcl-1 | Myeloid cell leukemia sequence-1 | Noxa, Bim, Puma, Bax, Bak | |
Bcl-2 | B-cell lymphoma 2 | Bad, Bim, Puma, Bmf, Bax | |
A1 | Bcl-2 related protein | Noxa, Bim, Puma, tBid, Hrk, Bik, Bax, Bak | |
Bcl-xL | Bcl-2-like | Bad, Bim, Puma, tBid, Hrk, Bmf, Bik, Bak, Bax | |
Bcl-w | Bcl-2-like-2 | Bad, Bim, Puma, tBid, Hrk, Bmf, Bik, Bax | |
Bcl-B | Bcl-2-like-10 | Bax | [44] |
BH3-only | Â | Â | Â |
Members: | Â | Â | Â |
Noxa | Phorbol-12-myristate-13-acetate-induced | Mcl-1, A1 | |
 | protein 1 |  |  |
Bad | Bcl-2 antagonist of cell death | Bcl-xL, Bcl-w, Bcl-2 | |
Bim | Bcl-2like-11 | Bcl-xL, Bcl-w, Bcl-2, Mcl-1, A1 | |
Puma | Bcl-2-binding component-3 | Bcl-xL, Bcl-w, Bcl-2, Mcl-1, A1 | |
tBid | truncated BH3-interacting | Bcl-xL, Bcl-w, A1 | |
 | domain death agonist |  |  |
Hrk | Harakiri | Bcl-xL, Bcl-w, A1 | [31] |
Bmf | Bcl-2-modifying factor | Bcl-xL, Bcl-w, Bcl-2 | |
Bik | Bcl-2-interacting killer | Bcl-xL, Bcl-w, A1 | [31] |
Effectors: | Â | Â | Â |
Bak | Bcl-2-antagonist/killer-1 | Bcl-xL, Mcl-1, A1 | |
Bax | Bcl-2-associated X protein | Bcl-xL, Bcl-w, Bcl-2, Bcl-B, Mcl-1, A1 |